Nicholas A. Ullman, MD, MSCI

R4 General Surgery Resident
University of Rochester Medical Center
Rochester, New York, United States

My name is Nicholas Ullman, MD and I am a fourth year clinical general surgery resident. I've previously completed a Post-Doctorate Research Fellowship as well as a Masters of Science in Clinical Investigating at the University of Rochester Medical Center. My research was in the Tumor Immology Research Lab, under Dr. David Linehan. My research interests were focused on chemokine disruption with combined checkpoint inhibition in both pancreatic adenocarcinoma and cholangiocarcinoma. I have applied to the Complex General Surgical Oncology fellowship.

Presentation(s):

• 38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy

  Thursday, March 23, 2023
  10:26 AM – 10:36 AM

  Disclosure information not submitted.

• P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study

  Friday, March 24, 2023
  1:21 PM – 1:26 PM

  Disclosure information not submitted.

• P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma

  Friday, March 24, 2023
  3:16 PM – 3:21 PM

  Disclosure information not submitted.

• 46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma

  Saturday, March 25, 2023
  9:56 AM – 10:06 AM

  Disclosure information not submitted.